TOMMY-HILFIGER
31.8.2020 08:02:04 CEST | Business Wire | Press release
Tommy Hilfiger, which is owned by PVH Corp. [NYSE:PVH] announces Make it Possible, a bold approach to environmental and social sustainability that reinforces the organization’s commitment to create fashion that ‘Wastes Nothing and Welcomes All’. With Make it Possible, Tommy Hilfiger is initially committing to 24 ambitious targets centered around circularity and inclusivity, outlined across four pillars towards 2030:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200830005002/en/
- Circle Round: Make products to be fully circular, and part of a sustainable loop.
- Made for Life: Operate with sensitivity to planetary boundaries, for instance in the areas of climate change, land use, freshwater and chemical pollution, from what we buy to where we sell.
- Everyone Welcome: Be a brand that works for every TOMMY Fan – always inclusive, completely accessible.
- Opportunity for All: Create equal access to opportunity – no barriers to success at Tommy Hilfiger.
Tommy Hilfiger’s program is powered by parent company PVH Corp’s Forward Fashion strategy, a set of 15 priorities designed to reduce negative impacts to zero, increase positive impacts to 100%, and improve the over 1 million lives across the company’s value chain.
“I opened my first store, People’s Place, in 1969 in my hometown of Elmira for people of all backgrounds to come together and share exciting pop culture experiences,” said Tommy Hilfiger. “As our brand has evolved over the years, driven by this inclusive spirit, so has our commitment to social and environmental sustainability. With Make it Possible, we will go even further with our commitment. We’re working towards our vision with the entire organization focused on it and, while we’re not there yet, we are going to get there.”
“In these times of health, human, environmental and economic crisis, we share a responsibility to find innovative solutions that will encourage inclusivity and build a more circular future,” said Martijn Hagman, CEO, Tommy Hilfiger Global and PVH Europe. “It is in our nature to drive change, even in the most challenging of times, which is why we are announcing our ambitious Make it Possible sustainability program, outlining 24 targets towards 2030. Tommy Hilfiger has a decade’s long track-record for driving a more sustainable future, including pioneering low impact denim processes, championing water stewardship, and creating more inclusive collections. Make it Possible is one way we will work together to make a meaningful and lasting contribution towards a better fashion industry.”
Make it Possible marks the latest milestone in Tommy Hilfiger’s sustainability journey. Key achievements include the launch of Tommy Hilfiger Adaptive , designed to make dressing easier for adults and children with disabilities, and the Tommy Hilfiger Fashion Frontier Challenge , a global program aimed to support start-up and scale-up stage businesses developing solutions that promote inclusivity and sustainability in fashion. More recently Tommy Hilfiger launched People’s Place Program to advance the representation of black, indigenous and people of color (BIPOC) communities within the fashion and creative industries. To date, more than 80% of Tommy Hilfiger designers have been trained on circular design strategies and, in 2019, 72% of cotton used globally came from more sustainable sources. Additionally 2 million pieces of denim have been finished in lower impact, reducing the amount of water and energy used. Each seasonal TOMMY HILFIGER collection includes more sustainable styles in its collections, as evidenced by the 50% more sustainable styles planned for Spring 2021, double the amount from Spring 2020.
Recognizing that no one company can change the sustainability landscape alone, Tommy Hilfiger, as part of PVH Corp., has joined forces with industry partners by signing The Fashion Pact in August 2019, as well as joining the Ellen MacArthur Foundation Make Fashion Circular and Jeans Redesign initiatives. For the past several years, Tommy Hilfiger has partnered with the WWF to address water risk in our strategic supply chain locations. This includes training on water risk management for suppliers and industrial parks in China’s Taihu River Basin and serving as the founding brand partner of a new water stewardship program in Vietnam in the Mekong basin.
Throughout its journey, Tommy Hilfiger will share its progress. For more information on Make it Possible and a full overview of achievements to date, visit: http://sustainability.tommy.com .
About Tommy Hilfiger
With a brand portfolio that includes TOMMY HILFIGER
and TOMMY JEANS
, Tommy Hilfiger is one of the world’s most recognized premium designer lifestyle groups. Its focus is designing and marketing high-quality men’s tailored clothing and sportswear, women’s collection apparel and sportswear, kidswear, denim collections, underwear (including robes, sleepwear and loungewear), footwear and accessories. Through select licensees, Tommy Hilfiger offers complementary lifestyle products such as eyewear, watches, fragrance, swimwear, socks, small leather goods, home goods and luggage. The TOMMY JEANS
product line consists of jeanswear and footwear for men and women, accessories, and fragrance. Merchandise under the TOMMY HILFIGER
and TOMMY JEANS
brands is available to consumers worldwide through an extensive network of TOMMY HILFIGER
and TOMMY JEANS
retail stores, leading specialty and department stores, select online retailers, and at tommy
.com
.
About PVH Corp.
PVH is one of the most admired fashion and lifestyle companies in the world. We power brands that drive fashion forward – for good. Our brand portfolio includes the iconic CALVIN KLEIN
, TOMMY HILFIGER
, Van Heusen
, IZOD
, ARROW, Warner’s
, Olga
and Geoffrey Beene
brands, as well as the digital-centric True&Co.
intimates brand. We market a variety of goods under these and other nationally and internationally known owned and licensed brands. PVH has over 40,000 associates operating in over 40 countries and $9.9 billion in annual revenues. That's the Power of Us. That’s the Power of PVH.
Follow us on Facebook , Instagram , Twitter and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200830005002/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release
Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
